Status:
COMPLETED
Preparation Rich in Growth Factors (PRGF) Treatment for Osteoarthritis of the Knee
Lead Sponsor:
Meir Medical Center
Conditions:
Osteoarthritis of the Knee
Eligibility:
All Genders
40-75 years
Phase:
PHASE2
PHASE3
Brief Summary
to evaluate the influence of PRGF treatment on patient suffering from OA knee
Detailed Description
Autologous platelet-secreted growth factors (GFs) may have therapeutic effects in osteoarthritis (OA) capsular joints via multiple mechanisms. Our aim is to examine the effect of a platelet-derived pr...
Eligibility Criteria
Inclusion
- age 40-75 years old
- diagnosed Oa of the knee more then 1 year
- no knee deformation
Exclusion
- mental of physical disabilities
- pregnancy
- deformities of the knee
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00728611
Start Date
January 1 2008
End Date
March 1 2009
Last Update
July 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel